BIO logo

BIOTON S.A. Stock Price

WSE:BIO Community·zł356.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BIO Share Price Performance

zł0
-3.67 (-100.00%)
zł0
-3.67 (-100.00%)
Price zł0

BIO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

1 Risk
1 Reward

BIOTON S.A. Key Details

zł282.5m

Revenue

zł190.7m

Cost of Revenue

zł91.8m

Gross Profit

zł88.4m

Other Expenses

zł3.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 29, 2026
0.04
32.49%
1.20%
6.6%
View Full Analysis

About BIO

Founded
1989
Employees
363
CEO
Jeremy Launders
WebsiteView website
www.bioton.pl

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

Recent BIO News & Updates

Recent updates

No updates